AblainLab

Studying adhesion and signaling in metastatic melanoma using #zebrafish @CRCL

[AblainLab @AblainLab]

Glad to see our last review out! Do you want to know more about dissemination in non-epithelial cancers? Check it out! @trendscancer @crcl @SerenaDiazzi
https://t.co/lQNNYXxbSn

[Serena Diazzi @SerenaDiazzi]

Thrilled to announce the release of our review on non-epithelial cancer dissemination! @trendscancer
Co-written with my post-doc mentor Julien Ablain @AblainLab to offer a fresh perspective on this emerging topic. Dive into the insights to discover more!
https://t.co/C8TLo61Qg7

[AblainLab @AblainLab]

Happy to see our paper out in @NatureGenet 🧬🐟 Big thanks to my previous lab @BCHStemCell @leonard_zon and my current lab @crcl for their work and support 🥼

[Nature Genetics @NatureGenet]

‼️ OUT NOW @NatureGenet
📰 Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion
🧑‍🤝‍🧑 @AblainLab @leonard_zon and team @BCHStemCell @crcl
👇🏿
https://t.co/i8yaVCnDqK
#melanoma #zebrafish

[Gabriel.Ichim @GabrielIchim1]

Summer picnic with the coolest lab mates from the @AblainLab, @ReprogrammingL and @GabrielIchim1 laboratories at the @CRCL

[Deckert Marcel @marcel_deckert]

Team MicroCan former student @SerenaDiazzi just gave a terrific talk 👏👏💪🤩@CanceropolePACA annual seminar on her work in our lab @SophieTartare @marcel_deckert @C3M_U1065 in collaboration with @Bernard_Mari1 lab

[AblainLab @AblainLab]

Huge congratulations to our amazing postdoc @viktorija_juric for getting #MSCA Postdoctoral Fellowship for the #MetaMelNiche project! Well done!

[Viktorija Juric @viktorija_juric]

Absolutely chuffed to have been awarded #MSCA Postdoctoral Fellowship for my #MetaMelNiche project. Massive thanks to my supervisor and lab @AblainLab 🔬🥼Fun journey ahead of us @crcl @MSCActions #msca2021

[DMM Journal @DMM_Journal]

Brand new review from Amira Al Mahi and Julien Ablain @crcl explores #RAS signalling in #melanoma to inform tumorigenesis and development of novel therapeutics for an array of cancers

📰https://t.co/pmgffcrLi8
#OpenAccess